Compare GTX & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GTX | TXG |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.6B |
| IPO Year | 2021 | 2019 |
| Metric | GTX | TXG |
|---|---|---|
| Price | $33.73 | $32.36 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 15 |
| Target Price | ★ $20.40 | $20.25 |
| AVG Volume (30 Days) | 2.8M | ★ 3.1M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.56% | N/A |
| EPS Growth | 20.63 | ★ 76.97 |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $3,584,000,000.00 | $245,893,000.00 |
| Revenue This Year | $4.16 | N/A |
| Revenue Next Year | $3.27 | $7.33 |
| P/E Ratio | $70.63 | ★ N/A |
| Revenue Growth | 3.14 | ★ 68.06 |
| 52 Week Low | $9.58 | $10.51 |
| 52 Week High | $35.06 | $35.65 |
| Indicator | GTX | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 63.52 | 64.80 |
| Support Level | $17.01 | $16.11 |
| Resistance Level | $34.34 | $35.65 |
| Average True Range (ATR) | 1.29 | 2.32 |
| MACD | -0.19 | 0.06 |
| Stochastic Oscillator | 74.01 | 58.15 |
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).